Form D — Nanocan Therapeutics Corp
0001820532-25-000003 · filed Feb 18, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $6,457,220
- Total sold
- $5,059,984
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nanocan Therapeutics Corp
- CIK
- 1820532
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 137 NATIONAL PLZ STE 300
NATIONAL HARBOR, MD 20745 - Phone
- (202) 258-1591
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Eric C. Broyles · Executive OfficerNATIONAL HARBOR, MD Find on LinkedIn ↗
-
Jacques P. Walker · Executive OfficerNATIONAL HARBOR, MD Find on LinkedIn ↗
-
Dave Krasne · Executive OfficerNATIONAL HARBOR, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗